188 filings
Page 4 of 10
8-K
IKT
Inhibikase Therapeutics Inc
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
IKT
Inhibikase Therapeutics Inc
25 Jan 23
Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Parkinson’s Disease
9:00am
8-K
IKT
Inhibikase Therapeutics Inc
24 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:27pm
8-K
IKT
Inhibikase Therapeutics Inc
17 Nov 22
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
4:30pm
10-Q
2022 Q3
IKT
Inhibikase Therapeutics Inc
Quarterly report
14 Nov 22
5:10pm
8-K
IKT
Inhibikase Therapeutics Inc
7 Nov 22
Inhibikase Therapeutics Announces FDA Clinical Hold on IkT-148009 Programs
4:01pm
8-K
IKT
Inhibikase Therapeutics Inc
16 Sep 22
Regulation FD Disclosure
4:09pm
4
Gisele Dion
6 Sep 22
Inhibikase Therapeutics / Gisele Dion ownership change
5:08pm
3
Gisele Dion
6 Sep 22
Inhibikase Therapeutics / Gisele Dion ownership change
5:06pm
8-K
IKT
Inhibikase Therapeutics Inc
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
4
Milton H. Werner
16 Aug 22
Inhibikase Therapeutics / Milton H. Werner ownership change
4:25pm
8-K
IKT
Inhibikase Therapeutics Inc
15 Aug 22
Regulation FD Disclosure
5:12pm
10-Q
2022 Q2
IKT
Inhibikase Therapeutics Inc
Quarterly report
12 Aug 22
4:33pm
8-K
IKT
Inhibikase Therapeutics Inc
28 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:55pm
8-K
IKT
Inhibikase Therapeutics Inc
29 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
4
Freeman Roy Lester
28 Jun 22
Inhibikase Therapeutics / Roy Lester Freeman ownership change
9:00pm
4
IKT
Inhibikase Therapeutics Inc
28 Jun 22
Inhibikase Therapeutics / PAUL C GRINT ownership change
9:00pm
4
IKT
Inhibikase Therapeutics Inc
28 Jun 22
Inhibikase Therapeutics / Elizabeth G. O'Farrell ownership change
9:00pm
4
IKT
Inhibikase Therapeutics Inc
28 Jun 22
Inhibikase Therapeutics / DENNIS N BERMAN ownership change
9:00pm
DEFR14A
IKT
Inhibikase Therapeutics Inc
22 Jun 22
Revised proxy
12:36pm